Sichuan Kelun-Biotech Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Nov '24 Nov 14, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	35,989	22,555	-	-
Enterprise Value	32,930	20,931	-	-
Last Close Price	161.50	102.90	-	-
PS Ratio	17.42	13.29	-	-
PB Ratio	10.44	8.79	-	-
P/TBV Ratio	10.72	8.79	-	-
P/OCF Ratio	-	343.75	-	-
EV/Sales Ratio	16.33	12.33	-	-
Debt / Equity Ratio	0.01	0.03	-0.93	-0.90
Asset Turnover	0.59	0.68	0.89	-
Inventory Turnover	9.41	13.00	5.36	-
Quick Ratio	5.51	2.35	0.05	0.04
Current Ratio	5.70	2.53	0.08	0.09
Return on Assets (ROA)	-3.59%	-12.59%	-27.27%	-
Return on Capital (ROIC)	-8.18%	-26.04%	-	-
Earnings Yield	-0.68%	-2.80%	-	-
FCF Yield	-1.64%	-0.10%	-	-
Buyback Yield / Dilution	-75.62%	-92.24%	-3.31%	-
Total Shareholder Return	-75.62%	-92.24%	-3.31%	-

Source: S&P Capital IQ. Standard template. Financial Sources.